Related Experiment Video
Updated: Dec 11, 2025

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
Published on: January 12, 2016
Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)
Saskia Antwerpes1, Camelia Protopopescu1,2, Philippe Morlat3
1Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, 13385 Marseille, France.
Insights
Regular coffee intake may preserve cognitive function in individuals coinfected with HIV and HCV. Elevated coffee consumption showed positive associations with verbal fluency, psychomotor speed, and executive functioning in this population.
Area of Science:
- Neuroscience
- Hepatology
- Infectious Diseases
Background:
- Coffee is a widely consumed beverage with known neuroprotective properties.
- HIV-HCV coinfection accelerates aging and causes cognitive impairment, impacting quality of life and treatment adherence.
- Understanding factors that support cognitive health in this population is crucial.
Purpose of the Study:
- To investigate the association between regular coffee intake and neurocognitive performance (NCP) in patients coinfected with HIV and HCV.
- To determine if elevated coffee intake (ECI) is linked to better cognitive outcomes in this specific cohort.
Main Methods:
- Analysis of data from 139 HIV-HCV coinfected patients from the ANRS CO13 HEPAVIH cohort and HEPAVIH-Psy survey.
- Linear regression models were employed, adjusting for sociodemographic, clinical, and socio-behavioral factors.
- Neurocognitive performance was assessed across various domains including verbal fluency, psychomotor speed, and executive functioning.
Main Results:
- A significant, positive association was found between elevated coffee intake (≥3 cups/day) and enhanced NCP.
- Specifically, ECI correlated with improvements in verbal fluency, psychomotor speed (coding), and executive functioning.
- No other factors showed such a consistent positive link to cognitive performance in this cohort.
Conclusions:
- Elevated coffee intake may play a protective role in maintaining neurocognitive functioning in individuals coinfected with HIV and HCV.
- Further research could explore the mechanisms behind coffee's neuroprotective effects in this vulnerable population.
- Findings suggest a potential lifestyle intervention to support cognitive health in HIV-HCV coinfected patients.
Abstract:
Coffee is one of the most consumed beverages worldwide. Previous research has demonstrated its neuroprotective effects in the elderly. People coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) experience an accelerated aging process and cognitive impairment, which significantly impair quality of life and may affect disease-related dimensions such as treatment adherence. This study aimed to analyse the relationship between regular coffee intake and neurocognitive performance (NCP) in HIV-HCV coinfected people. We used data from 139 coinfected patients who participated in both the ANRS CO13 HEPAVIH cohort and the HEPAVIH-Psy cross-sectional survey. Linear regression models adjusting for potential sociodemographic (age, gender, educational level), clinical (liver disease status, ongoing HCV treatment, HIV viral load, major depressive disorder) and socio-behavioural (cannabis use) correlates of NCP were used. Our results showed significant, positive associations between elevated coffee intake (ECI) (three or more cups of coffee per day) and NCP in verbal fluency, psychomotor speed (coding) and executive functioning. ECI might therefore preserve neurocognitive functioning in people living with HIV and HCV.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS Depressants: Alcohol and Nicotine
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetics: Drug–Food and Drug–Viral Interactions

